| 1 |
31630405 | Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease. | 2020 May |
1 |
| 2 |
30100615 | An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C. | 2019 Jun |
1 |
| 3 |
27737931 | Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin. | 2017 Jan |
2 |
| 4 |
21447733 | Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs. | 2011 Jul |
1 |
| 5 |
18612079 | Human proximal tubular epithelium actively secretes but does not retain rosuvastatin. | 2008 Oct |
1 |
| 6 |
18617601 | Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. | 2008 Oct |
2 |
| 7 |
16415124 | ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein. | 2006 May |
2 |